T-Therapeutics Ltd
Ilona Zvetkova has extensive work experience in the field of research and science. Ilona is currently employed as a Senior Scientist at T-Therapeutics Ltd since March 2023. Prior to this, they worked at the University of Cambridge where they held the positions of Senior Research Associate from October 2019 to present and Postdoctoral Research Associate from October 2007 to October 2019. Before their time at Cambridge, they worked as a Postdoctoral Research Associate at the Wellcome Sanger Institute from 2002 to 2007. Ilona also served as a Postdoctoral Research Associate at the MRC Clinical Sciences Centre (now MRC London Institute of Medical Sciences), Imperial College London from 1999 to 2002 and at the University of Warwick from 1996 to 1999.
Ilona Zvetkova received their education from the University of Warwick, where they completed their Doctor of Philosophy (PhD) degree in Cell/Cellular and Molecular Biology. Ilona pursued their studies at the university from 1992 to 1996.
T-Therapeutics Ltd
T-Therapeutics is a venture-backed company on a mission to unlock the power of T cells to treat chronic and infectious diseases. Based on technology from Professor Allan Bradley’s laboratory in Cambridge University’s Department of Medicine, T-Therapeutics has secured significant investment from a blue-chip syndicate of investors to support its drug discovery efforts and prepare candidates for clinical development. T-Therapeutics was founded in 2022, and we are at the very beginning of our journey to develop transformative T cell derived medicines. To realise our ambition, we are currently building facilities, recruiting staff, and establishing our research operations.